Nevoid basal cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome, is a rare hereditary condition characterized by a wide range of developmental abnormalities and a predisposition to neoplasms. The syndrome consists of early-onset and/or multiple BCC. Herein we report a rare NBCCS case in which the first BCC onset occurred in the groin area. To the best of our knowledge, there have been no reports of first-onset BCC in the groin area in an NBCCS patient of any race. 
We suspected nevoid basal carcinoma syndrome (NBCCS; Gorlin syndrome) and performed mutation detection. Mutation analysis of genomic DNA demonstrated the patient to be heterozygous for the mutation c.1364dupT (p.T456NfsX41) in PTCH1, a gene that functions in tumor suppression. The groin region had not been exposed to radiation or arsenic ingestion. She had no history of BCC.
Surgical excision was performed. The histopathologic findings under hematoxylin-eosin stain showed alveolar structures of various sizes, with basaloid tumor cells ( fig. 1b) . Characteristic peripheral palisading patterns were observed as well ( fig. 1c) . The histopathology was consistent with BCC.
Discussion
NBCCS, also known as Gorlin syndrome, was first reported in 1894 and was clearly defined in 1960 by Gorlin and Goltz [1] . NBCCS is a rare hereditary condition characterized by a wide range of developmental abnormalities and a predisposition to neoplasms. The gene responsible for NBCCS is the gene PTCH, which is on chromosome 9q22.3-q31 [2] . This inherited gene is a human tumor suppressor gene, and mutation in this gene increases the risk of BCC. The syndrome consists of early-onset and/or multiple BCCs, keratocysts of the jaw, palmar and plantar pits, calcified dural folds, hamartomas, various neoplasms, and skeleton anomalies such as bifid ribs and macrocephaly. As shown in table 1, the incidence varies widely among ethnic groups: 80% of Caucasian NBCCS patients manifest BCC, whereas only 38% of African patients manifest BCC [3] . Japanese NBCCS patients have an even lower frequency of BCC than those groups (table 1) . BCCs, whose number can vary from a few to hundreds, usually first appear between puberty and age 35; however, cases have been reported in patients as young as age 3 or 4. In Japanese NBCCS patients, the age of onset for BCC is much higher than in Caucasians [4] . BCC of the perianal and genital regions is rare, occurring at these sites in less than 1% of all BCCs. The frequency of BCC in the groin area is even rarer in patients with NBCCS.
There has been only one previous report of an NBCCS patient with a BCC in the groin area [5] . However, in that case, the patient previously had more than 15 BCCs, so the BCC in the groin area was not the first onset.
Herein we reported a rare NBCCS case in which the first BCC onset occurred in the groin area. To the best of our knowledge, there have been no reports of first-onset BCC in the groin area in an NBCCS patient of any race. In conclusion, long-term follow-up, complete and comprehensive skin examination, including non-sun-exposed areas, even if a detailed history reveals no arsenic ingestion or radiation exposure to these areas, is strongly recommended for NBCCS patients.
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